XS-04 / Fosun Pharma - LARVOL DELTA

A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies (clinicaltrials.gov) - P1 | N=168 | Recruiting | Sponsor: NovaOnco Therapeutics Co., Ltd. | Enrolling by invitation ➔ Recruiting

Enrollment status • Acute Myelogenous Leukemia • B Cell Lymphoma • Hematological Disorders • Hematological Malignancies • Leukemia • Lymphoma • Myelodysplastic Syndrome • Non-Hodgkin’s Lymphoma • Oncology